BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Ischemia
,
Adipose tissue
,
Anticancer prodrugs
,
Aspirin
,
rs2230926
,
TGFB1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fms like tyrosine kinase 3
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies.
Molecular involvement and prognostic importance of fms-like tyrosine kinase 3 in acute myeloid leuke…
Fms-like tyrosine kinase (FLT) 3 and FLT3 internal tandem duplication in different types of adult le…
Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at com…
Inhibition of fms-like tyrosine kinase 3 alleviates experimental arthritis by reducing formation of …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Early Access Program (EAP) of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FL…
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults F…
Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) M…
A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adul…
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolida…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ